The 6th Meeting of the Global Alliance to Eliminate Lymphatic Filariasis: A half-time review of lymphatic filariasis elimination and its integration with the control of other neglected tropical diseases

[1]  P. J. Hooper,et al.  The Economic Benefits Resulting from the First 8 Years of the Global Programme to Eliminate Lymphatic Filariasis (2000–2007) , 2010, PLoS neglected tropical diseases.

[2]  J. Williamson,et al.  Increasing Compliance with Mass Drug Administration Programs for Lymphatic Filariasis in India through Education and Lymphedema Management Programs , 2010, PLoS neglected tropical diseases.

[3]  J. Norões,et al.  A Mechanism for Chronic Filarial Hydrocele with Implications for Its Surgical Repair , 2010, PLoS neglected tropical diseases.

[4]  Shannon K. McClintock,et al.  A Community-Based Study of Factors Associated with Continuing Transmission of Lymphatic Filariasis in Leogane, Haiti , 2010, PLoS neglected tropical diseases.

[5]  S. Narahari,et al.  An integrative treatment for lower limb lymphedema (elephantiasis). , 2010, Journal of alternative and complementary medicine.

[6]  M. Deming,et al.  Mapping, monitoring, and surveillance of neglected tropical diseases: towards a policy framework , 2010, The Lancet.

[7]  S. Adjei,et al.  Integration of control of neglected tropical diseases into health-care systems: challenges and opportunities , 2010, The Lancet.

[8]  Eric A. Ottesen,et al.  Global programme to eliminate lymphatic filariasis. , 2010, Releve epidemiologique hebdomadaire.

[9]  B. Liese,et al.  Official development assistance for health-how neglected are neglected tropical diseases? An analysis of health financing. , 2009, International health.

[10]  J. Chai,et al.  Successful control of lymphatic filariasis in the Republic of Korea. , 2009, The Korean journal of parasitology.

[11]  P. Brantus.  Ten years of managing the clinical manifestations and disabilities of lymphatic filariasis , 2009, Annals of tropical medicine and parasitology.

[12]  M. Malecela,et al.  Lymphatic filariasis: patients and the global elimination programme , 2009, Annals of tropical medicine and parasitology.

[13]  A. Hoerauf,et al.  Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon , 2009, Parasites & Vectors.

[14]  A. Hoerauf,et al.  Reduction in levels of plasma vascular endothelial growth factor-A and improvement in hydrocele patients by targeting endosymbiotic Wolbachia sp. in Wuchereria bancrofti with doxycycline. , 2009, The American journal of tropical medicine and hygiene.

[15]  R. K. Shenoy,et al.  Antifilarial drugs, in the doses employed in mass drug administrations by the Global Programme to Eliminate Lymphatic Filariasis, reverse lymphatic pathology in children with Brugia malayi infection , 2009, Annals of tropical medicine and parasitology.

[16]  Shin-Hyeong Cho,et al.  Elimination of lymphatic filariasis in the Republic of Korea: an epidemiological survey of formerly endemic areas, 2002–2006 , 2009, Tropical medicine & international health : TM & IH.

[17]  E. Ottesen.  Global programme to eliminate lymphatic filariasis. , 2009, Releve epidemiologique hebdomadaire.

[18]  M. Bockarie,et al.  Role of vector control in the global program to eliminate lymphatic filariasis. , 2009, Annual review of entomology.

[19]  Steven A. Williams,et al.  Determinants of success in national programs to eliminate lymphatic filariasis: a perspective identifying essential elements and research needs. , 2008, The American journal of tropical medicine and hygiene.

[20]  P. Srivastava,et al.  Elimination of lymphatic filariasis in India--a successful endeavour. , 2008, Journal of the Indian Medical Association.

[21]  P. J. Hooper,et al.  The Global Programme to Eliminate Lymphatic Filariasis: Health Impact after 8 Years , 2008, PLoS neglected tropical diseases.

[22]  R. K. Shenoy,et al.  Lymphoscintigraphic evidence of lymph vessel dilation in the limbs of children with Brugia malayi infection. , 2008, The Journal of communicable diseases.

[23]  W. Shannon,et al.  The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt. , 2007, The American journal of tropical medicine and hygiene.

[24]  T. Ryan,et al.  Integrated management of filarial lymphedema for rural communities. , 2007, Lymphology.

[25]  R. K. Shenoy,et al.  Preliminary findings from a cross-sectional study on lymphatic filariasis in children, in an area of India endemic for Brugia malayi infection , 2007, Annals of tropical medicine and parasitology.

[26]  Molly A Brady,et al.  Morbidity management in the Global Programme to Eliminate Lymphatic Filariasis: a review of the scientific literature , 2007, Filaria journal.

[27]  A. Hoerauf,et al.  Doxycycline Reduces Plasma VEGF-C/sVEGFR-3 and Improves Pathology in Lymphatic Filariasis , 2006, PLoS pathogens.

[28]  W. Shannon,et al.  Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment , 2006, The Lancet.

[29]  Lymphatic filariasis: progress of disability prevention activities. , 2004, Releve epidemiologique hebdomadaire.

[30]  C. Mackenzie,et al.  Medical achievements under civil war conditions , 1999, The Lancet.

[31]  A. Hopkins.  [Partnerships and distribution of Mectizan. Distribution of ivermectin in countries at war]. , 1998, Sante.

[32]  M. Boussinesq,et al.  Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection , 1997, The Lancet.